← All patents

US20180099002A1

Tumor-selective combination therapy

University of Texas System

Abstract

The therapies described herein can be selectively lethal toward a variety of different cancer cell types and cancer conditions in a subject. The combination therapies described herein can be useful for the management, treatment, control, or adjunct treatment of diseases, where the selective …

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Paul J. Hergenrother
Priority date
April 09, 2013
Filing date
December 06, 2017
Publication date
April 12, 2018
Language
en
Metadata fetched
August 29, 2026 00:25